Lanean...
Glycosylated Haemoglobin (HbA(1)c) - A Marker of Circulating Lipids in Type 2 Diabetic Patients
Background: Diabetic patients with concomitant dyslipidemia are often soft targets for cardiovascular disease and deaths. An early intervention to normalize circulating lipids has been shown to reduce cardiovascular morbidity and mortality. Glycosylated hemoglobin (HbA(1)c) is routinely used as a ma...
Gorde:
| Egile Nagusiak: | , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
JCDR Research and Publications (P) Limited
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3972563/ https://ncbi.nlm.nih.gov/pubmed/24701471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7860/JCDR/2014/7742.3996 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|